Abstract
A MD simulation protocol was developed to model halogen bonding in protein–ligand complexes by inclusion of a charged extra point to represent the anisotropic distribution of charge on the halogen atom. This protocol was then used to simulate the interactions of cathepsin L with a series of halogenated and non-halogenated inhibitors. Our results show that chloro, bromo and iodo derivatives have progressively narrower distributions of calculated geometries, which reflects the order of affinity I > Br > Cl, in agreement with the IC50 values. Graphs for the Cl, Br and I analogs show stable interactions between the halogen atom and the Gly61 carbonyl oxygen of the enzyme. The halogen-oxygen distance is close to or less than the sum of the van der Waals radii; the C–X···O angle is about 170°; and the X···O=C angle approaches 120°, as expected for halogen bond formation. In the case of the iodo-substituted analogs, these effects are enhanced by introduction of a fluorine atom on the inhibitors’ halogen-bonding phenyl ring, indicating that the electron withdrawing group enlarges the σ-hole, resulting in improved halogen bonding properties.
Similar content being viewed by others
References
Desiraju GR, Ho PS, Kloo L, Legon AC, Marquardt R, Metrangolo P, Politzer P, Resnati G, Rissanen K (2013) Definition of the halogen bond (IUPAC Recommendations 2013). Pure Appl Chem 85:1711–1713
Politzer P, Lane P, Concha MC, Ma Y, Murray JS (2007) An overview of halogen bonding. J Mol Model 13:305–311
Metrangolo P, Neukirch H, Pilati T, Resnati G (2005) Halogen bonding based recognition processes: a world parallel to hydrogen bonding. Acc Chem Res 38:386–395
Clark T, Hennemann M, Murray J, Politzer P (2007) Halogen bonding: the σ-hole. J Mol Model 13:291–296
Metrangolo P, Murray JS, Pilati T, Politzer P, Resnati G, Terraneo G (2011) The fluorine atom as a halogen bond donor, viz a positive site. Cryst Eng Comm 13:6593–6596
Metrangolo P, Murray JS, Pilati T, Politzer P, Resnati G, Terraneo G (2011) Fluorine-centered halogen bonding: a factor in recognition phenomena and reactivity. Cryst Growth Des 11:4238–4246
Wilcken R, Zimmermann MO, Lange A, Zahn S, Boeckler FM (2012) Using halogen bonds to address the protein backbone: a systematic evaluation. J Comput Aided Mol Des 26:935–945
Politzer P, Murray JS, Concha MC (2007) Halogen bonding and the design of new materials: organic bromides, chlorides and perhaps even fluorides as donors. J Mol Model 13:643–650
Metrangolo P, Resnati G (2008) Halogen bonding: fundamentals and applications. Springer, Berlin
Scholfield MR, Zanden CMV, Carter M, Ho PS (2013) Halogen bonding (X-bonding): a biological perspective. Protein Sci 22:139–152
Lu Y, Shi T, Wang Y, Yang H, Yan X, Luo X, Jiang H, Zhu W (2009) Halogen bonding—A novel interaction for rational drug design? J Med Chem 52:2854–2862
Hardegger LA, Kuhn B, Spinnler B, Anselm L, Ecabert R, Stihle M, Gsell B, Thoma R, Diez J, Benz J, Plancher J-M, Hartmann G, Banner DW, Haap W, Diederich F (2011) Systematic investigation of halogen bonding in protein–ligand interactions. Angew Chem Int Ed 50:314–318
Xu Z, Liu Z, Chen T, Chen T, Wang Z, Tian G, Shi J, Wang X, Lu Y, Yan X, Wang G, Jiang H, Chen K, Wang S, Xu Y, Shen J, Zhu W (2011) Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors. J Med Chem 54:5607–5611
Wilcken R, Zimmermann MO, Lange A, Joerger AC, Boeckler FM (2013) principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 56:1363–1388
Ibrahim MAA (2011) Molecular mechanical study of halogen bonding in drug discovery. J Comput Chem 32:2564–2574
Rendine S, Pieraccini S, Forni A, Sironi M (2011) Halogen bonding in ligand-receptor systems in the framework of classical force fields. Phys Chem Chem Phys 13:19508–19516
Kolář M, Hobza P (2012) On extension of the current biomolecular empirical force field for the description of halogen bonds. J Chem Theory Comput 8:1325–1333
Jorgensen WL, Schyman P (2012) Treatment of halogen bonding in the OPLS-AA force field: application to potent anti-HIV agents. J Chem Theory Comput 8:3895–3901
Carter M, Rappé AK, Ho PS (2012) Scalable anisotropic shape and electrostatic models for biological bromine halogen bonds. J Chem Theory Comput 8:2461–2473
El Hage K, Piquemal J-P, Hobaika Z, Maroun RG, Gresh N (2013) Could an anisotropic molecular mechanics/dynamics potential account for sigma hole effects in the complexes of halogenated compounds? J Comput Chem 34:1125–1135
Du L, Gao J, Bi F, Wang L, Liu C (2013) A polarizable ellipsoidal force field for halogen bonds. J Comput Chem 34:2032–2040
Liu Y, Xu Z, Yang Z, Chen K, Zhu W (2013) A knowledge-based halogen bonding scoring function for predicting protein-ligand interactions. J Mol Model 19:5015–5030
Hardegger LA, Kuhn B, Spinnler B, Anselm L, Ecabert R, Stihle M, Gsell B, Thoma R, Diez J, Benz J, Plancher J-M, Hartmann G, Isshiki Y, Morikami K, Shimma N, Haap W, Banner DW, Diederich F (2011) Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments. ChemMedChem 6:2048–2054
Debouck C, Metcalf B (2000) The impact of genomics on drug discovery. Annu Rev Pharmacol Toxicol 40:193–207
Podgorski I (2009) Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis? Future Med Chem 1:21–34
Huryn DM, Smith AB 3rd (2009) The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for molecular discovery with cathepsin B and cathepsin L. Curr Top Med Chem 9:1206–1216
Schröder J, Klinger L, Oellien F, Marhöfer RJ, Duszenko M, Selzer PM (2013) Docking-based virtual screening of covalently-binding ligands: an orthogonal lead discovery approach. J Med Chem 56:1478–1490
Leto G, Sepporta MV, Crescimanno M, Flandina C, Tumminello FM (2010) Cathepsin L in metastatic bone disease: therapeutic implications. Biol Chem 391:655–664
Lafarge JC, Naour N, Clément K, Guerre-Millo M (2010) Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92:1580–1586
Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120:3421–3431
Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G (2012) Cysteine cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer’s disease. Biochim Biophys Acta 1824:89–104
Álvarez Sánchez R, Banner D, Ceccarelli SM, Grether U, Haap W, Hartman P, Hartmann G, Hilpert H, Kuehne H, Mauser H, Plancher J-M. (F. Hoffmann-La Roche A.G.), Novel Proline Derivatives. US20100267722 (A1), October 21, 2010
Riley KE, Murray JS, Fanfrlík J, Řezáč J, Solá RJ, Concha MC, Ramos FM, Politzer P (2011) Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine. J Mol Model 17:3309–3318
Bondi A (1964) van der Waals volumes and radii. J Phys Chem 68:441–451
Politzer P, Murray JS (2013) Enthalpy and entropy factors in gas phase halogen bonding: compensation and competition. Cryst Eng Comm 15:3145–3150
Wilcken R, Zimmerman MO, Lange A, Zahn S, Kirchner B, Boeckler FM (2011) Addressing methionine in molecular design through directed sulphur-halogen bonds. J Chem Theory Comput 7:2307–2315
Carter M, Voth AR, Scholfield MR, Rummel B, Sowers LC, Ho PS (2013) Enthalpy–entropy compensation in biomolecular halogen bonds measured in DNA junctions. Biochemistry 52:4891–4903
Acknowledgments
This study was supported by FONDECYT Grant 1110146.
Conflict of interest
The authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Celis-Barros, C., Saavedra-Rivas, L., Salgado, J.C. et al. Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition. J Comput Aided Mol Des 29, 37–46 (2015). https://doi.org/10.1007/s10822-014-9802-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-014-9802-7